Korea S.E.
03:30:00 12/06/2024 am IST
5-day change
1st Jan Change
1,167
KRW
+0.69%
-0.17%
-4.73%
WooGene B&G Co., Ltd. announced that it has received KRW 13 billion in funding from Hyundai Asset Management Co., Ltd.
On May 20, 2016, WooGene B&G Co., Ltd. closed the transaction. The company has received KRW 13,000,000,000 in funding.
WooGene B&G Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
20/03
CI
WooGene B&G Co., Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
14/11
CI
WooGene B&G Co., Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
14/23/14
CI
WooGene B&G Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
12/23/12
CI
WooGene B&G Co., Ltd announced that it has received KRW 8 billion in funding
23/23/23
CI
WooGene B&G Co., Ltd announced that it expects to receive KRW 8 billion in funding
21/23/21
CI
WooGene B&G Co., Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
11/22/11
CI
WooGene B&G Co., Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
12/22/12
CI
WooGene B&G Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
13/22/13
CI
WooGene B&G Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
22/22/22
CI
WooGene B&G Co., Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
12/21/12
CI
An unknown buyer cancelled the acquisition of 23.2% stake in WooGene Bio Co., Ltd. from WooGene B&G Co., Ltd..
16/20/16
CI
WooGene B&G Co., Ltd. announced that it has received KRW 3 billion in funding
15/20/15
CI
WooGene B&G Co., Ltd. announced that it expects to receive KRW 3 billion in funding
10/20/10
CI
An unknown buyer agreed to acquire 23.2% stake in WooGene Bio Co., Ltd. from WooGene B&G Co., Ltd. for KRW 2.9 billion.
16/19/16
CI
WooGene B&G Co., Ltd. announced that it expects to receive KRW 7.526523 billion in funding from Green Cross Veterinary Products Co., Ltd.
16/19/16
CI
WooGene B&G Co., Ltd. announced that it has received KRW 10 billion in funding from Hana Ventures, Aju Investment Co. Ltd., Mirae Asset Daewoo Co., Ltd. and other investor
14/19/14
CI
WooGene B&G Co., Ltd. agreed to acquire OSP Co., Ltd. from Taejun Kim, Hyewon Kim and Jiwon Kim for KRW 22.5 billion.
14/19/14
CI
WooGene B&G Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Hana Ventures, Aju Investment Co. Ltd., Mirae Asset Daewoo Co., Ltd.and another investor
01/19/01
CI
WooGene B&G Co., Ltd. announced that it has received KRW 5 billion in funding
03/19/03
CI
WooGene B&G Co., Ltd. announced that it expects to receive KRW 5 billion in funding
30/19/30
CI
WooGene B&G Co., Ltd. announced that it has received KRW 13 billion in funding from Hyundai Asset Management Co., Ltd.
20/16/20
CI
WooGene B&G Co., Ltd. announced that it expects to receive KRW 11 billion in funding from Hyundai Asset Management Co., Ltd. and other investors.
16/16/16
CI
WooGene B&G Co., Ltd.’s Equity Buyback announced on October 10, 2008 has expired.
02/14/02
CI
WooGene B&G Co., Ltd. Extends Equity Buyback till May 2, 2014
30/13/30
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
WooGene B&G Co., Ltd. is a Korea-based company mainly engaged in the manufacture of veterinary drugs. The Companyâs products include anti-infective, bulk materials, probiotics, enzymes, antiparasitics, hormone preparations, vaccines, aquacultures, anesthetics, teat dips, disinfectants, pet cure drugs, calcium injections, antiphlogistic injections, enhance metabolism injections, diarrhea remedy injections, sedative injections for swine, toxin binders, pigmentation drugs and others. The Company also provides anti-inflammatory enzymes under the brand name SKD, which are used for human beings. The Company distributes its products within domestic market and to overseas markets, including Iran, Vietnam, Philippines, Brazil and others.
More about the company
1st Jan change
Capi.
-4.73% 24.69M -13.18% 80.24B +19.43% 8.84B +23.62% 3.66B -4.59% 3.2B +14.02% 1.78B -0.39% 1.31B -27.76% 1.2B -30.02% 1.17B -22.42% 1.01B
Veterinary Drugs
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
WOOGENE B&G CO., LTD 
